• About
CMM
Karolinska institutet
Karolinska universitetssjukhuset
Sök

Martin Schalling Team

About

The aim of Martin Schallings’ research is to identify genetic, epigenetic and environmental factors that predispose to the development of neuropsychiatric and metabolic disorders such as depression, anorexia, schizophrenia, malnutrition in kidney disorder and obesity. His research group focus on genetic/epigenetic studies and functional studies in tissues and cell culture. KIgene, a core fascility for genetic and genomic analysis is housed within the C.Lavebratt & M.Schalling group. KIgene supports research both within KI and outside and specialize in rapid and accurate turnaround, normally delivering data the day after recieving samples for analysis.

Team leader

Martin Schalling, professor, martin.schalling@ki.se

About CMM

The Center for Molecular Medicine (CMM) is a foundation instituted by the Stockholm County Council (Region Stockholm). CMM is at the heart of a close partnership with the Karolinska University Hospital and Karolinska Institutet, fueling advancements in biomedical and clinical research.

Contact

Center for Molecular Medicine Foundation, org. nr. 815201-3689

Karolinska University Hospital L8:05

Visionsgatan 18

171 76 Stockholm, Sweden

communication@cmm.se

CMM
Karolinska institutet
Karolinska universitetssjukhuset